P N Madras

Author PubWeight™ 17.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Two hundred one consecutive living-donor nephrectomies. Arch Surg 1998 1.75
2 Controversies in organ donation: the altruistic living donor. Nephrol Dial Transplant 2001 1.45
3 Acute aortic thrombosis presenting as painless paraplegia. J Cardiovasc Surg (Torino) 1989 1.16
4 Aortoiliac reconstruction following renal transplantation. Surgery 1982 1.09
5 Prostaglandin E1 therapy for digital ulcers in scleroderma. Can Med Assoc J 1982 1.00
6 Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg 1998 0.90
7 Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients. Transplantation 1989 0.87
8 Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease. Arch Surg 1997 0.86
9 Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Transplantation 1997 0.83
10 Anastomotic hyperplasia. Surgery 1981 0.81
11 Hemodynamic evaluation of intra-aortic balloon pumping in man. Circulation 1970 0.80
12 The effect of Coumadin upon thrombus forming on foreign surfaces. Artif Organs 1980 0.80
13 Portacaval shunt for familial heterozygous hypercholesterolemia. Surg Gynecol Obstet 1981 0.80
14 Predictive value of pretransplant IL-2 levels in kidney transplantation. Transplant Proc 1991 0.79
15 Sequential interleukin 2 and interleukin 2 receptor levels distinguish rejection from cyclosporine toxicity in liver allograft recipients. Arch Surg 1991 0.78
16 Femoropopliteal bypass: saphenous vein and expanded polytetrafluoroethylene grafts. Can J Surg 1982 0.77
17 Renal transplantation in the diabetic. World J Surg 1986 0.77
18 Immunologic heterogeneity among potential transplant recipients. Prospects for predicting immune responses to allografts with in vitro tests. Clin Lab Med 1991 0.76
19 Reduction in complement activation from biomaterials by removal of air nuclei from the surface roughness. J Biomed Mater Res 1984 0.75
20 Use of Dacron cuffed silicone catheters as long-term hemodialysis access. ASAIO J 1992 0.75
21 Ascending aorta to bilateral femoral artery graft via a ventral subcutaneous route. Ann Surg 1977 0.75
22 Numerical simulation of blood and plasma flow through the Petschek flow chambers. Artif Organs 1981 0.75
23 Cytologic examination of urinary sediment in renal allograft recipients. Transplant Proc 1989 0.75
24 Theoretical and experimental analysis of the intra-aortic balloon pump. Trans Am Soc Artif Intern Organs 1968 0.75
25 Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants. Transplant Proc 1997 0.75
26 Intra-aortic balloon assist pumping: effectiveness and limitations. Surg Forum 1968 0.75
27 Left heart assist system: intra-aortic balloom pump. Surg Clin North Am 1969 0.75
28 Progression of peripheral vascular disease after combined kidney-pancreas transplantation in diabetic patients with end-stage renal failure. Transplant Proc 1997 0.75
29 Combined kidney and pancreas transplantation. A 3-year experience. Arch Surg 1992 0.75
30 Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. Transplant Proc 1996 0.75
31 Dynamics of thrombus formation. Fed Proc 1972 0.75
32 Stress-related subintimal hyperplasia. Transplant Proc 1987 0.75
33 Origin of elevated IL-2 and IL-2R in the urine of rejecting renal allograft recipients. Transplant Proc 1989 0.75
34 Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients. Ann Pharmacother 1992 0.75
35 Is proximal reconstruction alone adequate treatment for combined aortoiliac and femoropopliteal disease? Can J Surg 1980 0.75
36 Enhanced thromboresistance of surfaces by denucleation. Trans Am Soc Artif Intern Organs 1980 0.75
37 Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up. Arch Surg 1995 0.75
38 Etiology of early renal allograft dysfunction after live donor renal transplantation. Transplant Proc 1998 0.75
39 Enhancement of thrombus formation by vascular prostheses. Can J Surg 1980 0.75
40 Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). Transplantation 1995 0.75
41 A single-center experience with six-antigen-matched kidney transplants. Arch Surg 1995 0.75
42 Intra-arterial alprostadil for nonatherosclerotic vasculopathy. JAMA 1981 0.75
43 Sequential IL-2 and IL-2R levels predict rejection in liver allograft recipients. Transplant Proc 1991 0.75
44 Laparoscopic versus open donor nephrectomy. Kidney Int 2000 0.75
45 Conformational stress and anastomotic hyperplasia. J Vasc Surg 1984 0.75
46 Monitoring the renal allograft by immunofluorescence of tubular epithelial cells in the urine sediment. Transplant Proc 1984 0.75
47 Cadaver donor hyperglycemia does not impair long-term pancreas allograft survival or function. Transplant Proc 1994 0.75
48 Correlation of binding of human immunoglobulin, urinary cytology, and needle biopsy in the early posttransplant period. Transplant Proc 1987 0.75
49 Binding of antihuman globulin by exfoliated renal tubular cells following kidney transplantation. Transplantation 1985 0.75
50 Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection. Transplant Proc 1989 0.75
51 Effects of prolonged intra-aortic balloon pumping. Trans Am Soc Artif Intern Organs 1969 0.75